Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tomusange

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Public Health|February 12, 2025
Mental health phenotypes of well-controlled HIV in UgandaLeah H Rubin, Kyu Cho, Jacob Bolzenius, et al.
Journal of Neurovirology|June 22, 2026
Cognitive and sensorimotor impairments in virally suppressed people with and without HIV in Uganda: Associations with neurofilament light chain as a biomarker of neuronal injuryK Ridgeway, Raha M Dastgheyb, Rebecca E Easter, et al.
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
The Journal of Infectious Diseases|April 18, 2026
Bacterial dysbiosis, cervicovaginal human papillomaviruses and inflammation persist in women living with HIV-1 after a year of antiretroviral treatmentAndrea Lisco, Alessandra Borgognone, Christophe Vanpouille, et al.
Virus Evolution|August 7, 2023
Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, UgandaEdward Nelson Kankaka, Andrew D Redd, Amjad Khan, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Public Health|February 12, 2025
Mental health phenotypes of well-controlled HIV in UgandaLeah H Rubin, Kyu Cho, Jacob Bolzenius, et al.
Journal of Neurovirology|June 22, 2026
Cognitive and sensorimotor impairments in virally suppressed people with and without HIV in Uganda: Associations with neurofilament light chain as a biomarker of neuronal injuryK Ridgeway, Raha M Dastgheyb, Rebecca E Easter, et al.
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
The Journal of Infectious Diseases|April 18, 2026
Bacterial dysbiosis, cervicovaginal human papillomaviruses and inflammation persist in women living with HIV-1 after a year of antiretroviral treatmentAndrea Lisco, Alessandra Borgognone, Christophe Vanpouille, et al.
Virus Evolution|August 7, 2023
Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, UgandaEdward Nelson Kankaka, Andrew D Redd, Amjad Khan, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Pageof 2